The characteristics of circular disposable devices and in situ devices for optimizing male circumcision: a network meta-analysis. By Fan et al., May 2016 http://www.ncbi.nlm.nih.gov/pubmed/271563682016
Male Circumcision for HIV Prevention.
WHO TAG on Innovations on Male Circumcision, 30 September – 2 October 2014, Geneva, Switzerland.
Shenje J, Millard PS. Sutureless Adult Voluntary Male Circumcision with Topical Anesthetic: A Randomized Field Trial of Unicirc, a Single-Use Surgical Instrument. PLoS One. 2016;11(6):e0157065. doi: 10.1371/journal.pone.0157065. PubMed PMID: 27299735.
No-Needle, Single-Visit Adult Male Circumcision with Unicirc: A Multi-Centre Field Trial. By Peter Millard and N.D.Goldstuck, PLOS, 2015, www.ncbi.nlm.nih.gov/pubmed/25822727
WHO Prequalification of Male Circumcision Devices
PUBLIC REPORT, Product: ShangRing™, Number: PQMC 0003-003-00, 2015
The PrePex Device Is Unlikely to Achieve Cost-Savings Compared to the Forceps-Guided Method in Male Circumcision Programs in Sub-Saharan Africa. By Obiero et al. University of Illinois at Chicago School of Public Health, Illinois, USA, 2013
Evaluating Opportunities for Achieving Cost Efficiencies Through the Introduction of PrePex Device Male Circumcision in Adult VMMC Programs in Zambia and Zimbabwe. http://www.ncbi.nlm.nih.gov/pubmed/27331598J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S90-5. doi:10.1097/QAI.0000000000000722.
Comparative Cost Analysis of Surgical and PrePex Device Male Circumcision in Zimbabwe and Mozambique.
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S96-S100. doi:10.1097/QAI.0000000000000797.
http://www.ncbi.nlm.nih.gov/pubmed/27331599
Odor, pain, delayed wound healing and risk of Infection with necrotising devices:
HIV Shedding from Male Circumcision Wounds in HIV-Infected Men: A Prospective Cohort Study. By A.R.Tobian et al. Published April 28, 201, http://dx.doi.org/10.1371/journal.pmed.1001820
Notes from the Field: Tetanus Cases After Voluntary Medical Male Circumcision for HIV Prevention--Eastern and Southern Africa, 2012-2015. MMWR Morbidity and mortality weekly report. 2016;65(2):36-7. doi: 10.15585/mmwr.mm6502a5. PubMed PMID: 26797167.
http://www.ncbi.nlm.nih.gov/pubmed/27331586J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S24-9. doi: 10.1097/QAI.0000000000000736.
Factors Associated With Delayed Healing in a Study of the PrePex Device for Adult Male Circumcision in Kenya.
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S43-8. doi: 10.1097/QAI.0000000000000742.
Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia. http://www.ncbi.nlm.nih.gov/pubmed/27331589
PMID: 27331589 [PubMed - in process]
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S73-7. doi: 10.1097/QAI.0000000000000765.
Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana.
PMID: 27331595 [PubMed - in process]
Demand creation and suitability of necrotising devices to replace surgical method:
http://www.ncbi.nlm.nih.gov/pubmed/27331597
Employing Demand-Based Volumetric Forecasting to Identify Potential for and Roles of Devices in Scale-Up of Medical Male Circumcision in Zambia and Zimbabwe.
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S83-9. doi: 10.1097/QAI.0000000000000991.
J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S36-42. doi: 10.1097/QAI.0000000000000799.
Safety Profile of PrePex Male Circumcision Device and Client Satisfaction With Adolescent Males Aged 13-17 Years in Zimbabwe. PMID: 27331588 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/27331596J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1:S78-82. doi: 10.1097/QAI.0000000000000703.
Perceptions of the PrePex Device Among Men Who Received or Refused PrePex Circumcision and People Accompanying Them.
PMID: 27331596 [PubMed - in process]